ZA905997B - Medicaments - Google Patents

Medicaments

Info

Publication number
ZA905997B
ZA905997B ZA905997A ZA905997A ZA905997B ZA 905997 B ZA905997 B ZA 905997B ZA 905997 A ZA905997 A ZA 905997A ZA 905997 A ZA905997 A ZA 905997A ZA 905997 B ZA905997 B ZA 905997B
Authority
ZA
South Africa
Prior art keywords
medicaments
Prior art date
Application number
ZA905997A
Other languages
English (en)
Inventor
Steven John Cooper
John Cooper Steven
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA905997B publication Critical patent/ZA905997B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA905997A 1989-08-01 1990-07-31 Medicaments ZA905997B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898917556A GB8917556D0 (en) 1989-08-01 1989-08-01 Medicaments

Publications (1)

Publication Number Publication Date
ZA905997B true ZA905997B (en) 1991-06-26

Family

ID=10660972

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA905997A ZA905997B (en) 1989-08-01 1990-07-31 Medicaments

Country Status (8)

Country Link
EP (1) EP0411900A3 (fr)
JP (1) JPH03218311A (fr)
KR (1) KR910004190A (fr)
CA (1) CA2022379A1 (fr)
GB (1) GB8917556D0 (fr)
IE (1) IE902769A1 (fr)
IL (1) IL95245A (fr)
ZA (1) ZA905997B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
JPH06508836A (ja) * 1991-06-26 1994-10-06 セプラコア,インコーポレーテッド 光学的に純粋なr(+)オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
JP2002538102A (ja) 1999-03-01 2002-11-12 セプラコア インコーポレーテッド 光学的に純粋なr(+)オンダンセトロンを使用する無呼吸および無呼吸障害の治療方法
CN104274395A (zh) * 2014-09-19 2015-01-14 威海爱威制药有限公司 盐酸昂丹司琼氯化钠注射液及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol

Also Published As

Publication number Publication date
IL95245A0 (en) 1991-06-10
IL95245A (en) 1995-03-15
JPH03218311A (ja) 1991-09-25
GB8917556D0 (en) 1989-09-13
IE902769A1 (en) 1991-02-27
KR910004190A (ko) 1991-03-28
EP0411900A2 (fr) 1991-02-06
CA2022379A1 (fr) 1991-02-02
EP0411900A3 (en) 1992-09-09

Similar Documents

Publication Publication Date Title
GB8905400D0 (en) Medicaments
AP8900136A0 (en) Medicaments
GB8916947D0 (en) Medicaments
GB8905815D0 (en) Medicament
ZA904716B (en) Medicaments
GB9019659D0 (en) Medicaments
GB8805269D0 (en) Medicaments
GB8814726D0 (en) Medicaments
GB8805268D0 (en) Medicaments
ZA905997B (en) Medicaments
GB8928208D0 (en) Medicaments
GB8808599D0 (en) Medicaments
GB8911166D0 (en) Medicaments
GB8814725D0 (en) Medicaments
GB8927286D0 (en) Medicaments
ZA907136B (en) Medicaments
GB8920235D0 (en) Medicaments
GB8922591D0 (en) Medicaments
GB8923644D0 (en) Medicaments
GB8923645D0 (en) Medicaments
GB8924587D0 (en) Medicaments
GB8926273D0 (en) Medicaments
GB8920393D0 (en) Medicaments
GB8902756D0 (en) Medicaments
GB8920391D0 (en) Medicaments